The 21st century:

The era of precision medicine

Dr. Henk Joos

01.06.2017

Helsinki

From Mass Disease treatment model to novel Precision Health Management

Prevention Diagnosis Treatment Care

A patient driven journey in novel precision health management

Mass Treatment Drug companies Doctors Patients

Hospitals

Multiple

dimensions in

novel health

management

Life

Sciences

Drive

Technology

Drive

Disease

Focus

Disease focus Oncology

Inflammation and Immune

diseases

CNS

Infectious diseases

Technology Drive Nano electronics

ICT and smart data

3D printing

Mechatronics

Life Sciences Drive Vaccinology and Immunology

Microbiome

Regenerative Medicine

Life

Sciences

Drive

Technology

Drive

Flanders is a key player in precision medicine

Disease

Focus

Flanders as one of the EU catalyzers

Life

Sciences

Drive

Technology

Drive

Disease

Focus

C3-SAXONY –

CROSSCLUSTER COOPERATION IN SAXONY

Flanders as one of the EU catalyzers

Life

Sciences

Drive

Technology

Drive

Disease

Focus

Cover the entire value chain

o Basic > applied > translational

research

o Create a business environment

o Combine knowledge and

technologies

o Realise step-changes for

patients: prevention & cure &

care

o Accessible & affordable

treatments

7 November 2016 LoI

o Flanders – the Netherlands top

in Ghent

RegMed XB – a case example for smart specialisation

Building a regeneration core in Europe: the ongoing step

www.regmed.be

Key hurdles for Precision Medicine

Multi-disciplinary Talent

Regulatory systems not up to date and founded in different worlds (life sciences vs technology)

Need for new collaboration and business models

Empowerment of Innovation through SME’s

Engagement of patients and society at large (e.g. human sample foundation for scientific purposes)

Financing of SME’s and academic research Seed financing

Product and service delivery financing

Multi-disciplinary collaboration is key